William Nguyen
Datos Biográficos
| ID | 7016284 |
|---|---|
| NOMBRE | William Nguyen |
| NOMBRES | William |
| APELLIDO | Nguyen |
| FIRMA | NGUYEN W |
| AFILIACIONES | University of California, San Francisco |
| ORCID | 0009-0004-3594-6186 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 3 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 3 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2021 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
Micro-costing for national-scale azithromycin mass drug administration to improve child survival in Niger
As programs for azithromycin mass drug administration (AZ-MDA) to reduce child mortality have begun in some parts of West Africa, it is imperative to understand their financial costs. We combined a micro-costing framework and observations from an implementation-focused sub-study within the AVENIR trials in 80 communities in the Dosso region of Niger to estimate the national health sector financial costs of a scaled-up programmatic approach for az…
Comparison of door-to-door and fixed-point delivery of azithromycin distribution for child survival in Niger
Recent evidence indicates mass azithromycin distribution reduces under-5 mortality. This intervention is being considered for child survival programs in high mortality sub-Saharan African settings. The delivery approach used in prior studies required a full-time census and distribution team, which is not feasible for most programs. To determine the optimal programmatic approach to delivery, this study aimed to compare treatment coverage, costs, a…
Age-based targeting of biannual azithromycin distribution for child survival in Niger
This trial was registered on January 13, 2020 (clinicaltrials.gov: NCT04224987 )
Sin obras prominentes en esta página.
Age-based targeting of biannual azithromycin distribution for child survival in Niger
This trial was registered on January 13, 2020 (clinicaltrials.gov: NCT04224987 )
Comparison of door-to-door and fixed-point delivery of azithromycin distribution for child survival in Niger
Recent evidence indicates mass azithromycin distribution reduces under-5 mortality. This intervention is being considered for child survival programs in high mortality sub-Saharan African settings. The delivery approach used in prior studies required a full-time census and distribution team, which is not feasible for most programs. To determine the optimal programmatic approach to delivery, this study aimed to compare treatment coverage, costs, a…
Micro-costing for national-scale azithromycin mass drug administration to improve child survival in Niger
As programs for azithromycin mass drug administration (AZ-MDA) to reduce child mortality have begun in some parts of West Africa, it is imperative to understand their financial costs. We combined a micro-costing framework and observations from an implementation-focused sub-study within the AVENIR trials in 80 communities in the Dosso region of Niger to estimate the national health sector financial costs of a scaled-up programmatic approach for az…
Azithromycin (3 obras) · Global Maternal and Child Health (3 obras) · Environmental health (2 obras) · Medicine (2 obras) · Population (2 obras) · Randomized controlled trial (2 obras) · Surgery (2 obras) · Antibiotics (1 obras) · Baseline (sea) (1 obras) · Child mortality (1 obras)